- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07711691
Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+) (Empower LCS+)
Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+): A Multi-Site Pilot Randomized Controlled Trial
Lung cancer screening (LCS) with low-dose computed tomography (LDCT) can reduce the risk of dying from lung cancer, but many people who are eligible for screening do not receive it. The purpose of the Empower LCS/Call+ study is to evaluate new strategies to improve lung cancer screening among adults who are eligible for screening based on current U.S. Preventive Services Task Force (USPSTF) guidelines.
This pilot randomized controlled trial will enroll approximately 80 participants from UC Irvine Health and Emory Healthcare. Participants will be randomly assigned to receive either enhanced usual care or the Empower LCS/Call+ intervention. The intervention includes educational materials, reminders for patients and primary care providers, and information about financial and community resources when appropriate. Participants who do not complete lung cancer screening after the initial intervention may receive additional telephone-based navigation through the Call+ program to help identify and address barriers to screening and help with scheduling.
Participants will complete a baseline survey and follow-up surveys at 4 and 8 months, and researchers will review electronic health record information to determine whether lung cancer screening was discussed, ordered, and completed. Some participants will also be invited to complete a one-time interview about their experiences with the study.
The results of this study will help determine the feasibility, acceptability, and preliminary effectiveness of the Empower LCS/Call+ intervention and will inform future efforts to improve equitable access to lung cancer screening.
Přehled studie
Postavení
Detailní popis
Lung cancer is the leading cause of cancer-related death in the United States. Although annual lung cancer screening with LDCT is recommended for adults at high risk and has been shown to reduce lung cancer mortality, screening uptake remains low. Barriers to screening exist at the patient, provider, and health system levels, including limited awareness of screening eligibility, incomplete documentation of smoking history in the electronic health record, logistical challenges, financial concerns, and psychosocial barriers such as fear, stigma, and mistrust.
The Empower LCS is a multilevel intervention designed to improve lung cancer screening uptake by combining patient education, provider notification, patient reminders, and information on financial and community resources. The intervention demonstrated improvements in lung cancer screening discussions and low-dose computed tomography ordering and completion compared with enhanced usual care in prior pilot study.
The current study evaluates an enhanced version of the intervention, Empower LCS/Call+. Participants who have not completed lung cancer screening after the initial intervention will be eligible to receive the Call+ telephone navigation intervention. Call+ is delivered by lay navigators and is designed to identify participant-specific barriers to screening, provide education and motivational support, facilitate primary care or imaging scheduling when appropriate, connect participants with available financial or community resources, and encourage completion of recommended lung cancer screening.
This prospective, multi-site, pilot randomized controlled trial will enroll participants from UC Irvine Health and Emory Healthcare. Potentially eligible participants will be identified using a combination of structured data and natural language processing of free text notes to extract smoking history from electronic medical records. Eligibility will be confirmed via self-report.
Participants will be randomly assigned to receive either the Empower LCS/Call+ intervention or enhanced usual care. Data will be collected through participant surveys, electronic health record review, intervention process measures, and qualitative interviews with a subset of participants to evaluate implementation experiences.
The primary purpose of this pilot study is to evaluate the feasibility, acceptability, and preliminary effectiveness of the enhanced intervention while providing implementation data to inform future randomized trials.
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
- Jméno: Gelareh Sadigh, MD
- Telefonní číslo: (714) 456-3610
- E-mail: gsadigh@hs.uci.edu
Studijní místa
-
-
California
-
Anaheim, California, Spojené státy, 92801
- UCI Health Family Health Center - Anaheim
-
Kontakt:
- Gelareh Sadigh, MD
- Telefonní číslo: (714) 456-3610
- E-mail: empowerlcs@hs.uci.edu
-
Costa Mesa, California, Spojené státy, 92627
- UCI Health - Costa Mesa
-
Kontakt:
- Gelareh Sadigh, MD
- Telefonní číslo: (714) 456-3610
- E-mail: empowerlsc@hs.uci.edu
-
Irvine, California, Spojené státy, 92697
- UCI Health Gottschalk Medical Plaza
-
Kontakt:
- Gelareh Sadigh, MD
- Telefonní číslo: (714) 456-3610
- E-mail: empowerlcs@hs.uci.edu
-
Irvine, California, Spojené státy, 92612
- CHAO Family Comprehensive Cancer Center- Irvine
-
Kontakt:
- Gelareh Sadigh, MD
- Telefonní číslo: (714) 456-3610
- E-mail: empowerlcs@hs.uci.edu
-
Laguna Hills, California, Spojené státy, 92653
- UCI Health - Laguna Hills
-
Kontakt:
- Gelareh Sadigh, MD
- Telefonní číslo: (714) 456-3610
- E-mail: empowerlcs@hs.uci.edu
-
Newport Beach, California, Spojené státy, 92660
- UCI Health - Newport Beach MacArthur
-
Kontakt:
- Gelareh Sadigh, MD
- Telefonní číslo: (714) 456-3610
- E-mail: gsadigh@hs.uci.edu
-
Orange, California, Spojené státy, 92868
- UCI Chao Family Comprehensive Cancer Center
-
Kontakt:
- Gelareh Sadigh, MD
- Telefonní číslo: (714) 456-3610
- E-mail: empowerlcs@hs.uci.edu
-
Orange, California, Spojené státy, 92868
- UCI Health SeniorHealth Center -Pavillion 4
-
Orange, California, Spojené státy, 92868
- UCI Medical Center, Pavilion 3
-
Kontakt:
- Gelareh Sadigh, MD
- Telefonní číslo: (714) 456-3610
- E-mail: empowerlcs@hs.uci.edu
-
Orange, California, Spojené státy, 92868
- Primary Care & Internal Medicine Services
-
Kontakt:
- Gelareh Sadigh, MD
- Telefonní číslo: (714) 456-3610
- E-mail: empowerlcs@hs.uci.edu
-
Santa Ana, California, Spojené státy, 92701
- UCI Health Family Health Center - Santa Ana
-
Kontakt:
- Gelareh Sadigh, MD
- Telefonní číslo: (714) 456-3610
- E-mail: empowerlcs@hs.uci.edu
-
Tustin, California, Spojené státy, 92670
- UCI Health - Tustin
-
Kontakt:
- Gelareh Sadigh, MD
- Telefonní číslo: (714) 456-3610
- E-mail: empowerlcs@hs.uci.edu
-
Yorba Linda, California, Spojené státy, 92886
- UCI Health - Yorba Linda
-
Kontakt:
- Gelareh Sadigh, MD
- Telefonní číslo: (714) 456-3610
- E-mail: empowerlcs@hs.uci.edu
-
-
Georgia
-
Alpharetta, Georgia, Spojené státy, 30009
- Emory at Avalon - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Atlanta, Georgia, Spojené státy, 30047
- Emory Clinic at Old Fourth Ward
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Atlanta, Georgia, Spojené státy, 30308
- Emory Clinic at Midtown
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Atlanta, Georgia, Spojené státy, 30309
- Emory at Peachtree Hills - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Atlanta, Georgia, Spojené státy, 30322
- Emory Clinic at 1365 Clifton Road - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-7271483
- E-mail: empowerlcs@emory.edu
-
Atlanta, Georgia, Spojené státy, 30322
- Emory Clinic at 1525 Clifton Road - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Atlanta, Georgia, Spojené státy, 30329
- Emory at Toco Hills - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Atlanta, Georgia, Spojené státy, 30342
- Emory Gastroenterology
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Atlanta, Georgia, Spojené státy, 30345
- Emory at Northlake - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Buford, Georgia, Spojené státy, 30519
- Emory at Buford - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Decatur, Georgia, Spojené státy, 30030
- Emory at Decatur - Primary Care (Irvin Court)
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Decatur, Georgia, Spojené státy, 30030
- Emory at Decatur - Primary Care (Scott Boulevard)
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Decatur, Georgia, Spojené státy, 30030
- Emory Clinic Downtown Decatur
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Decatur, Georgia, Spojené státy, 30033
- Emory at Decatur - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Decatur, Georgia, Spojené státy, 30033
- Emory at Oak Grove - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Decatur, Georgia, Spojené státy, 30033
- Emory Clinic at Decatur - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Decatur, Georgia, Spojené státy, 30034
- Emory at Flat Shoals - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Duluth, Georgia, Spojené státy, 30096
- Emory at Duluth
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Duluth, Georgia, Spojené státy, 30097
- Emory at Sugarloaf - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Dunwoody, Georgia, Spojené státy, 30338
- Emory at Dunwoody
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Dunwoody, Georgia, Spojené státy, 30342
- Emory Clinic at Saint Joseph's
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Johns Creek, Georgia, Spojené státy, 30097
- Emory at Findley Road
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Jonesboro, Georgia, Spojené státy, 30236
- Emory at Spivey Station - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
La Grange, Georgia, Spojené státy, 30240
- Emory at LaGrange - Smith Street - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
La Grange, Georgia, Spojené státy, 30241
- Emory at LaGrange - Davis Road
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Lilburn, Georgia, Spojené státy, 30047
- Emory at Beaver Ruin - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Lilburn, Georgia, Spojené státy, 30047
- Emory at Mountain Park - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Lithonia, Georgia, Spojené státy, 30058
- Emory at Hillandale Family Medicine
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Lithonia, Georgia, Spojené státy, 30058
- Emory at Miller Grove - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Lithonia, Georgia, Spojené státy, 30058
- Emory Clinic at Lithonia - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Marietta, Georgia, Spojené státy, 30068
- Emory at East Cobb - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Peachtree City, Georgia, Spojené státy, 30269
- Emory at Peachtree City - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Sharpsburg, Georgia, Spojené státy, 30277
- Emory at Sharpsburg
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Smyrna, Georgia, Spojené státy, 30080
- Emory at Belmont - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Snellville, Georgia, Spojené státy, 30078
- Emory at Snellville - Primary Care (Lenora Church Road)
-
Kontakt:
- il Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Snellville, Georgia, Spojené státy, 30078
- Emory at Snellville - Primary Care (Oak Road)
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Snellville, Georgia, Spojené státy, 30078
- Emory at Snellville Primary Care (Presidential Circle)
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Snellville, Georgia, Spojené státy, 30339
- Emory at Centerville - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Stockbridge, Georgia, Spojené státy, 30281
- Emory at Eagles Landing Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Stone Mountain, Georgia, Spojené státy, 30083
- Emory at Stone Mountain - Primary Care
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Stone Mountain, Georgia, Spojené státy, 30087
- Emory at Rockbridge Primary Care & Nephrology
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Tucker, Georgia, Spojené státy, 30084
- Emory at Tucker - Primary Care (1459 Montreal Road)
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
Warner Robins, Georgia, Spojené státy, 31093
- Pavilion Family Medicine Center
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
West Point, Georgia, Spojené státy, 31833
- Emory at West Point
-
Kontakt:
- Ilana Graetz, PhD
- Telefonní číslo: 404-727-1483
- E-mail: empowerlcs@emory.edu
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Popis
Inclusion Criteria:
- Must meet current USPSTF eligibility criteria for lung cancer screening (Current criteria: age 50-80 years old with a 20 pack-year smoking history, who currently smoke or have quit within the last 15 years)
- Must have an electronic health record-assigned primary care provider within University of California Irvine Health or Emory Healthcare
- Must have recent engagement with respective health system (i.e., office or emergency department (ED) visit, hospitalization with discharged home in the last 12 months, or a scheduled office visit in the next 3 months).
- Must speak English or Spanish
- Able and willing to provide informed consent
Exclusion Criteria:
- Meet the eligibility upper age limit during initial 4-month participation.
- Have a prior history of lung cancer.
- Have a new diagnosis of other cancers in the 12 months
- Have a chest CT or LDCT in the last 12 months
- Have ICD-10 code of Alzheimer's disease in EHR
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Výzkum zdravotnických služeb
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Aktivní komparátor: Enhanced Usual Care
Usual care + educational brochure
|
Obvyklá péče
One-page educational material about benefits and risks of lung cancer screening
|
|
Experimentální: Empower LCS/Call+
Empower LCS with Call+ offered to non-responders
|
Obvyklá péče
Empower LCS consists of (1) a lung cancer screening decision aid, (2) primary care provider notification of patients' eligibility for lung cancer screening, (3) patient text reminders to discuss lung cancer screening with their primary care provider, and (4) tailored support materials including financial education and national/local resources for patients who screen positive for health-related social needs.
Participants who do not complete lung cancer screening by approximately 4 months after randomization will receive the Call+, a telephone-based navigation intervention delivered by a lay navigator to identify and address barriers to screening, facilitate scheduling, and connect participants with available resources.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Completion of lung cancer screening with low-dose computed tomography (LDCT)
Časové okno: 4 months after randomization
|
Completion of LDCT lung cancer screening, determined by electronic health record review.
|
4 months after randomization
|
|
Completion of lung cancer screening with low-dose computed tomography (LDCT)
Časové okno: 8 months after randomization
|
Completion of LDCT lung cancer screening, determined by electronic health record review.
|
8 months after randomization
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Completion of any chest CT
Časové okno: 4 months after randomization
|
Completion of any chest CT, determined by electronic health record review.
|
4 months after randomization
|
|
Completion of any chest CT
Časové okno: 8 months after randomization
|
Completion of any chest CT
|
8 months after randomization
|
|
Ordering of low-dose computed tomography (LDCT)
Časové okno: 4 months after randomization
|
Provider order for LDCT identified through electronic health record review.
|
4 months after randomization
|
|
Ordering of low-dose computed tomography (LDCT)
Časové okno: 8 months after randomization
|
Provider order for LDCT identified through electronic health record review.
|
8 months after randomization
|
|
Discussion of lung cancer screening with a primary care provider
Časové okno: 4 months after enrollment
|
Electronic health record documentation of discussion regarding lung cancer screening with primary care provider.
|
4 months after enrollment
|
|
Discussion of lung cancer screening with a primary care provider
Časové okno: 8 months after enrollment
|
Electronic health record documentation of discussion regarding lung cancer screening with primary care provider.
|
8 months after enrollment
|
|
Lung cancer screening scheduling
Časové okno: 4 months post-randomization
|
scheduling of lung cancer screening as self-reported by patient
|
4 months post-randomization
|
|
Patient knowledge of lung cancer screening
Časové okno: 4 months after randomization
|
Participant knowledge regarding lung cancer screening assessed via 9-item survey previously used (Shojazadeh et al.
JACR; 2025)
|
4 months after randomization
|
|
Decisional conflict regarding lung cancer screening
Časové okno: 4 months after randomization
|
Participant decisional conflict measured using 10-item decisional conflict scale (O'Connor AM)
|
4 months after randomization
|
|
Perceived lung cancer risk
Časové okno: 4 months after randomization
|
Perceived lung cancer risk will be measured using 3-item validated survey (Carter-Harris et al.
Cancer Nurs; 2017)
|
4 months after randomization
|
|
Perceived lung cancer severity
Časové okno: 4 months after randomization
|
Perceived lung cancer severity will be measured using 5-item survey (Shojazadeh et al.
JACR; 2015)
|
4 months after randomization
|
|
Perceived lung cancer screening benefits
Časové okno: 4 months after randomization
|
Perceived lung cancer screening benefits will be measured using 6-item validated survey (Carter-Harris et al.
Cancer Nurs; 2017)
|
4 months after randomization
|
|
Perceived lung cancer screening barriers
Časové okno: 4 months after randomization
|
Perceived lung cancer screening barriers will be measured using 18-item validated survey (Carter-Harris et al.
Cancer Nurs; 2017)
|
4 months after randomization
|
|
Perceived lung cancer screening self-efficacy
Časové okno: 4 months after randomization
|
Perceived lung cancer screening self-efficacy will be measured using 9-item validated survey (Carter-Harris et al.
Cancer Nurs; 2017)
|
4 months after randomization
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Vrchní vyšetřovatel: Ilana Graetz, PhD, Emory University
- Vrchní vyšetřovatel: Gelareh Sadigh, University of California, Irvine
Publikace a užitečné odkazy
Obecné publikace
- O'Connor AM. Validation of a decisional conflict scale. Med Decis Making. 1995 Jan-Mar;15(1):25-30. doi: 10.1177/0272989X9501500105.
- National Lung Screening Trial Research Team; Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873. Epub 2011 Jun 29.
- Carter-Harris L, Slaven JE 2nd, Monohan P, Rawl SM. Development and Psychometric Evaluation of the Lung Cancer Screening Health Belief Scales. Cancer Nurs. 2017 May/Jun;40(3):237-244. doi: 10.1097/NCC.0000000000000386.
- Quezada JJ, Avenido AR, Jia S, Bernaba A, Nguyen S, Gharagozlou SS, Nguyen TQ, Keshava H, Sadigh G. Assessing Providers' knowledge about and barriers to lung cancer screening. Cancer Treat Res Commun. 2024;41:100850. doi: 10.1016/j.ctarc.2024.100850. Epub 2024 Nov 15.
- Shojazadeh A, Kao R, Pham T, Madan A, Echeverria R, Chen WP, Nguyen V, Gutierrez O, Lee S, Hoyt MA, Ziogas A, Nguyen TQ, Keshava H, Sadigh G. A Multilevel Approach to Improve Participation in Low-Dose CT for Lung Cancer Screening (Empower LCS): A Single-Arm Pilot Feasibility Clinical Trial. J Am Coll Radiol. 2026 Apr;23(4):556-564. doi: 10.1016/j.jacr.2025.11.005. Epub 2025 Nov 13.
- Jung J, Razzak E, Avenido AR, Rashidi A, Jia S, Tran NQ, Yao R, Nguyen EL, Bernaba A, Echeverria R, Nguyen TQ, Imanzadeh A, Sadigh G. Patient-Reported Barriers and Preferred Interventions to Improve Lung Cancer Screening Uptake. J Am Coll Radiol. 2025 Mar;22(3):269-279. doi: 10.1016/j.jacr.2024.10.010.
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Odhadovaný)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- STUDY00001802
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
Časový rámec sdílení IPD
Kritéria přístupu pro sdílení IPD
Typ podpůrných informací pro sdílení IPD
- PROTOKOL STUDY
- ICF
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .